Historic Global Goods: Difference between revisions
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
=Maturity of Global Goods: Summary Table=
=Maturity of Global Goods: Summary Table=
This table reflects the maturity model baseline assessments and the latest reassessment of global goods funded through Digital Square. All maturity model assessments are *self-reported* by the funded organization leading the software development of the global good. For more information about global good maturity models, please contact Carl Fourie at cfourie@path.org.
This table reflects the maturity model baseline assessments and the historical reassessment of global goods funded through Digital Square. All maturity model assessments are *self-reported* by the funded organization leading the software development of the global good. For more information about global good maturity models, please contact Carl Fourie at cfourie@path.org.


{| class="wikitable"
{| class="wikitable"
Line 16: Line 16:
|style="background-color:#96d68f; border-bottom:solid 5px black" | 9
|style="background-color:#96d68f; border-bottom:solid 5px black" | 9
|style="background-color:#f7e5ab; border-bottom:solid 5px black" | 6
|style="background-color:#f7e5ab; border-bottom:solid 5px black" | 6
|rowspan="1" style="border-bottom:solid 5px black"| N/A
|-
|rowspan="1" style="border-bottom:solid 5px black" | [[#OpenHIE|OpenHIE]]
|style="border-bottom:solid 5px black" | Baseline (July 2021)
|style="background-color:#96d68f; border-bottom:solid 5px black" | 8
|style="background-color:#f7e5ab; border-bottom:solid 5px black" | 6
|style="background-color:#f7abab; border-bottom:solid 5px black" | 1
|rowspan="1" style="border-bottom:solid 5px black"| N/A
|rowspan="1" style="border-bottom:solid 5px black"| N/A
|-
|-
Line 39: Line 32:
|rowspan="1" style="border-bottom:solid 5px black"| N/A
|rowspan="1" style="border-bottom:solid 5px black"| N/A
|-
|-
|}


=Maturity by Global Good=
=Maturity by Global Good=
Line 162: Line 156:
|}
|}


==OpenHIE (Content Global Good)==
 
==Pharmadex==


{| class="wikitable"
{| class="wikitable"
Line 172: Line 167:
|-
|-
! scope="row" | Country Utilization
! scope="row" | Country Utilization
|style="background-color:#96d68f" | High
|style="background-color:#f7e5ab" | Medium
|-
|-
! scope="row" | Country Strategy
! scope="row" | Country Strategy
|style="background-color:#96d68f" | High
|style="background-color:#f7e5ab" | Medium
|-
|-
! scope="row" | Digital Health Interventions
! scope="row" | Digital Health Interventions
|style="background-color:#BFBFBF" | N/A
|style="background-color:#96d68f" | High
|-
|-
! scope="row" | Source Code Accessibility
! scope="row" | Source Code Accessibility
|style="background-color:#BFBFBF" | N/A
|style="background-color:#96d68f" | High
|-
|-
! scope="row" | Funding and Revenue
! scope="row" | Funding and Revenue
|style="background-color:#f7abab" | Low
|style="background-color:#96d68f" | High
|-
|-
! scope="col" colspan="3" | Community
! scope="col" colspan="3" | Community
Line 195: Line 190:
|-
|-
! scope="row" | Software Roadmap
! scope="row" | Software Roadmap
|style="background-color:#f7e5ab" | Medium
|style="background-color:#96d68f" | High
|-
|-
! scope="row" | User Documentation
! scope="row" | User Documentation
|style="background-color:#f7e5ab" | Medium
|style="background-color:#96d68f" | High
|-
|-
! scope="row" | Multi-lingual Support
! scope="row" | Multi-lingual Support
|style="background-color:#f7abab" | Low
|style="background-color:#96d68f" | High
|-
|-
! scope="col" colspan="3" | Software
! scope="col" colspan="3" | Software
|-
|-
! scope="row" | Technical Documentation  
! scope="row" | Technical Documentation  
|style="background-color:#BFBFBF" | N/A
|style="background-color:#96d68f" | High
|-
|-
! scope="row" | Software Productization
! scope="row" | Software Productization
|style="background-color:#BFBFBF" | N/A
|style="background-color:#f7e5ab" | Medium
|-
|-
! scope="row" | Interoperability and Data Accessibility
! scope="row" | Interoperability and Data Accessibility
|style="background-color:#BFBFBF" | N/A
|style="background-color:#f7e5ab" | Medium
|-
|-
! scope="row" | Security
! scope="row" | Security
|style="background-color:#BFBFBF" | N/A
|style="background-color:#96d68f" | High
|-
|-
! scope="row" | Scalability
! scope="row" | Scalability
|style="background-color:#BFBFBF" | N/A
|style="background-color:#f7e5ab" | Medium
|-
|-
|}
|}

Latest revision as of 17:39, 15 February 2023

Maturity of Global Goods: Summary Table

This table reflects the maturity model baseline assessments and the historical reassessment of global goods funded through Digital Square. All maturity model assessments are *self-reported* by the funded organization leading the software development of the global good. For more information about global good maturity models, please contact Carl Fourie at cfourie@path.org.

Global Good Global Utility Community Software Change
ODK-X Baseline (July 2021) 7 9 6 N/A
Pharmadex Baseline (July 2021) 8 10 7 N/A
Healthsites Baseline (March 2021) 6 8 8 N/A

Maturity by Global Good

Healthsites

Category Update (March 2021)
Global Utility
Country Utilization Medium
Country Strategy Medium
Digital Health Interventions High
Source Code Accessibility High
Funding and Revenue Low
Community
Developer, Contributor, and Implementer Community Engagement High
Community Governance High
Software Roadmap Medium
User Documentation High
Multi-lingual Support Medium
Software
Technical Documentation Medium
Software Productization Medium
Interoperability and Data Accessibility High
Security High
Scalability High

ODK-X

Category Baseline (July 2021)
Global Utility
Country Utilization Low
Country Strategy High
Digital Health Interventions High
Source Code Accessibility High
Funding and Revenue Medium
Community
Developer, Contributor, and Implementer Community Engagement High
Community Governance High
Software Roadmap High
User Documentation High
Multi-lingual Support Medium
Software
Technical Documentation Medium
Software Productization High
Interoperability and Data Accessibility Medium
Security Medium
Scalability Medium


Pharmadex

Category Baseline (July 2021)
Global Utility
Country Utilization Medium
Country Strategy Medium
Digital Health Interventions High
Source Code Accessibility High
Funding and Revenue High
Community
Developer, Contributor, and Implementer Community Engagement High
Community Governance High
Software Roadmap High
User Documentation High
Multi-lingual Support High
Software
Technical Documentation High
Software Productization Medium
Interoperability and Data Accessibility Medium
Security High
Scalability Medium
Retrieved from "https://wiki.digitalsquare.io/index.php?title=Historic_Global_Goods&oldid=2205"